Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Esophageal Squamous Cell Carcinoma 11Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Lymphatic Metastasis 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thymoma 1Thymic epithelial tumor 1Solid Tumor Cancer 1Recurrence 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Recurrence, Local 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Radiotherapy 5Cisplatin 5pembrolizumab 4Cyclophosphamide 4Thymectomy 3Sunitinib 3130-nm albumin-bound paclitaxel 3selinexor 2Pemetrexed 2Methylprednisolone 2Etoposide 2Drug Therapy 2Doxorubicin 2Chemoradiotherapy 2Carboplatin 2zimberelimab 1vorolanib 1regorafenib 1lenvatinib 1epacadostat 1envafolimab 1bosutinib 1amrubicin 1Thoracic Surgery, Video-Assisted 1TP protocol 1Ramucirumab 1Radiotherapy, Adjuvant 1Radiosurgery 1Radiofrequency Ablation 1Radiation Dose Hypofractionation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thymoma × TP protocol × Clear all
NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Korean Cancer Study Group

Phase 2 Terminated
39 enrolled
Thoracic

Thymic epithelial tumor, Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡